One of our collaborations speaking at the 21st International Vasculitis Workshop in Barcelona, how many more collaborations do we have out there??
MONDAY, 8 APRIL | 08:00-09:45 | ROOM 112
Add to calendar
O-002. Manipulation of the gut microbiome protects from kidney inflammation and injury in experimental myeloperoxidase anti neutrophil cytoplasmic antibody vasculitis.
Speaker: Kim Maree O'Sullivan. Monash University, Melbourne, Australia
---------------------------------------------------
The human trials is obviously very important, but how many things could our IP be connected with for ALL kinds or research/income possibitities ?????????????????
One of our collaborations speaking at the 21st International...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $3.003K | 428.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 131873 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 2066479 | 11 |
View Market Depth
| Last trade - 11.55am 25/06/2024 (20 minute delay) ? |
| PAB (ASX) Chart |